Core Viewpoint - The company, Madi Technology (603990), has announced the termination of its fourth employee stock ownership plan and will change the use of repurchased shares to cancellation in order to reduce registered capital and enhance per-share earnings, thereby boosting investor confidence [1][2]. Group 1: Recent Events - The company has decided to terminate the fourth employee stock ownership plan ahead of schedule, which was originally intended to raise a maximum of 7.6345 million yuan, corresponding to 1.0373 million shares (accounting for 0.34% of the total share capital) [2]. Group 2: Company Status - The purpose of the repurchased 1.0373 million shares will be changed from "for employee stock ownership plan" to "cancellation and reduction of registered capital," resulting in a decrease of total share capital from 306 million shares to 305 million shares [3]. - The aforementioned matters will require approval at the shareholders' meeting before implementation, with the specific timing to be announced later. If approved, the changes in share structure will be finalized by the China Securities Depository and Clearing Corporation [4].

Core Viewpoint - The company has established a joint venture with Shenzhen Youbikong Technology Co., Ltd. to focus on the development and application of healthcare robots in medical and wellness scenarios [1] Group 1: Company Developments - The joint venture, named Suzhou Youmai Robot Co., Ltd., aims to explore the integration of artificial intelligence and humanoid robot technology with wellness services [1] - The company's healthcare robot business targets typical needs in elderly care institutions, rehabilitation hospitals, and home healthcare [1] - The company has officially launched the "Xiaomai" healthcare companion robot V1.0, which has received the "Healthcare Companion Robot No. 001" certification [1] Group 2: Market Engagement - The company is actively participating in multiple pilot projects and the construction of smart wellness platforms across various cities [1] - Several projects have been implemented in multiple cities, establishing testing scenarios for the company's healthcare solutions [1]

证券代码：603990 证券简称：麦迪科技 公告编号：2026-008 一、 公司募集资金现金管理到期赎回情况 公司分别于 2025 年 12 月 31 日、2026 年 1 月 13 日、2026 年 1 月 14 日向浙 商银行苏州分行营业部办理了银行七天通知存款业务。截至本公告披露日，公司 已将上述产品赎回，收回本金共 4,500 万元，获得理财收益 1.99 万元。 上述产品具体情况如下： 单位：人民币万元 | 受托方 | 产品名 | 认购金 | 起息日 | | | 到期日 | | | 赎回金 | 理财收 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 称 | 额 | | | | | | | 额 | 益 | | 浙商银行 苏州分行 | 银行七 天通知 | 500 | 2025 年 | 12 | 月 | 2026 | 年 | 2 月 | 500 | 0.34 | | 营业部 | 存款 | | 31 | 日 | | 2 | 日 | | | | | 浙商银行 | 银行七 | | 2026 | 年 | 1 | ...

Core Viewpoint - The company, Suzhou Mediston Medical Technology Co., Ltd., is forecasting a turnaround in its financial performance for the year 2025, expecting to achieve profitability after a loss in the previous year [2][3]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of the parent company between 39 million and 44 million yuan for 2025, compared to a loss of approximately 279.47 million yuan in the previous year [2][3]. - The expected net profit after deducting non-recurring gains and losses is projected to be between 10 million and 15 million yuan [4]. - The performance forecast covers the period from January 1, 2025, to December 31, 2025 [2]. Group 2: Previous Year Performance - In 2024, the company reported a total profit of -253.73 million yuan, with a net loss attributable to shareholders of the parent company at -279.47 million yuan, and a net loss after deducting non-recurring gains and losses of -367.42 million yuan [6]. - The earnings per share for the previous year were -0.92 yuan per share [7]. Group 3: Reasons for Turnaround - The company attributes the expected turnaround to the completion of a significant asset sale, which involved divesting its photovoltaic business. This strategic move is part of a broader focus on core medical operations, enhancing asset-light attributes, and building a platform-based ecosystem [8]. - The company aims to optimize its business structure and improve operational stability through refined management practices, thereby enhancing profitability [8].

2025年1月1日至2025年12月31日。 证券代码：603990 证券简称：麦迪科技 公告编号：2026-007 苏州麦迪斯顿医疗科技股份有限公司 2025 年年度业绩预告（更新版） 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 本期业绩预告情况 （一）业绩预告期间 公司不存在可能影响本次业绩预告内容准确性的重大不确定因素。 五、 其他说明事项 本期业绩预告适用情形:预计净利润实现扭亏为盈。 苏州麦迪斯顿医疗科技股份有限公司（以下简称"麦迪科技"或"公 司"）预计 2025 年归属于母公司所有者的净利润为 3,900 万元至 4,400 万元，预计 2025 年年度归属于母公司所有者的扣除非经常性损益后的 净利润为 1,000 万元至 1,500 万元,预计 2025 年实现营业收入 30,000 万元至 35,000 万元。 （二）业绩预告情况 1、经财务部门初步测算，预计2025年年度实现归属于母公司所有者的净利 润为3,900万元至4,400万元，上年同期为-27,947.47万元，将实现扭亏 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders of 39 million to 44 million yuan for 2025, a significant turnaround from a net loss of 279.47 million yuan in 2024[5] - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between 10 million and 15 million yuan[5] - The company reported a total profit of -253.73 million yuan and a net profit attributable to shareholders of -279.47 million yuan for 2024[6] - The performance forecast is based on preliminary calculations and has not been audited, with final figures to be disclosed in the official 2025 annual report[9] - The performance forecast period is from January 1, 2025, to December 31, 2025[5] Strategic Initiatives - The main reason for the turnaround is the completion of a major asset sale and the divestment of the photovoltaic business, allowing the company to focus on its core medical business[7] - The company aims to enhance its operational efficiency and cost control through refined management practices, which is expected to improve profitability[7] - The company is focusing on three strategic initiatives: concentrating on the medical core business, enhancing asset-light attributes, and building a platform ecosystem[7] Caution for Investors - The company emphasizes that there are no significant uncertainties that could affect the accuracy of this performance forecast[8] - Investors are advised to be cautious as the forecast data is preliminary and subject to change[9]

Core Viewpoint - The company, MediTech (603990.SH), expects a net profit attributable to shareholders of the parent company to be between 39 million and 44 million yuan for 2025, with a net profit excluding non-recurring gains and losses projected to be between 10 million and 15 million yuan [1] Group 1 - The main reason for the turnaround to profitability is the impact of the photovoltaic business, which resulted in a negative net profit for 2024 [1] - In 2025, the company plans to complete a significant asset sale to divest from the photovoltaic business [1] - The company is focusing on three strategic initiatives: concentrating on the medical core business, enhancing asset-light attributes, and building a platform-based ecosystem to optimize its business structure and improve operational stability [1] Group 2 - The company aims to enhance its profitability through refined management practices, continuously improving operational efficiency and cost control [1]

Core Viewpoint - The company, MediTech, expects to achieve a turnaround in profitability for the fiscal year 2025, projecting a net profit attributable to shareholders of 39 million to 44 million yuan, compared to a loss of 279 million yuan in the same period last year [1] Financial Projections - The anticipated net profit for 2025 represents a significant improvement, indicating a shift from a previous loss to profitability [1] - The company also forecasts a net profit, excluding non-recurring gains and losses, of 10 million to 15 million yuan for the same period [1]

证券代码：603990 证券简称：麦迪科技 公告编号：2026-005 根据《股权转让合同》与《股权转让合同的补充合同》约定，本次交易以现 金方式支付，共分两期支付。第一期为上市公司召开股东大会审议本次交易相关 议案并通过后 30 个工作日内，安建投资向麦迪科技支付炘皓新能源股权转让价 款的 51%，即 30,468.23 万元，苏州炘诺向麦迪科技支付麦迪电力现金股权转让 价款的 51%，即 539.66 万元；第二期为交割日后 12 个月内，安建投资向麦迪科 技支付炘皓新能源股权转让价款的 49%（即 29,273.40 万元）及对应利息，苏州 炘诺向麦迪科技支付麦迪电力现金股权转让价款的 49%（即 518.50 万元）及对 应利息。 截至 2025 年 1 月 25 日，公司已收到安建投资支付的炘皓新能源股权转让价 款的51%，即30,468.23万元，苏州炘诺支付的麦迪电力现金股权转让价款的51%， 即 539.66 万元。具体情况详见公司于 2025 年 1 月 25 日披露的相关公告。 2026 年 1 月 26 日，公司已收到由苏州炘诺支付的麦迪电力现金股权转让价 款的 49%及对应利息合计 5 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2026-004 苏州麦迪斯顿医疗科技股份有限公司 关于使用部分闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第四届董事会第三十一次会议、第四届监事会第十五次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在确保不影 响募集资金投资项目进度和募集资金安全的前提下，对暂时闲置的部分募集资金 不超过人民币 2 亿元（包含本数）进行现金管理，余额在上述额度内，资金可以 滚动使用，用于购买单笔期限最长不超过 12 个月（含 12 个月）的结构性存款等 安全性高的保本型产品，不得用于证券投资。公司董事会、监事会及保荐机构已 分别对前述事项发表了同意的意见。具体内容详见公司于 2025 年 4 月 30 日披露 的《关于使用部分闲置募集资金进行现金管理的公告》(公告编号：2025-025)。 单位：人民币万元 | 受托方 | 产品名 ...